NuCana Plc (NCNA)
1.47
-0.05
(-3.29%)
USD |
NASDAQ |
Aug 24, 16:00
1.47
0.00 (0.00%)
After-Hours: 20:00
NuCana Total Assets (Quarterly) : 34.22M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 34.22M |
| March 31, 2026 | 36.33M |
| December 31, 2025 | 40.13M |
| September 30, 2025 | 43.50M |
| June 30, 2025 | 22.22M |
| March 31, 2025 | 14.97M |
| December 31, 2024 | 18.50M |
| September 30, 2024 | 26.20M |
| June 30, 2024 | 25.37M |
| March 31, 2024 | 31.33M |
| December 31, 2023 | 35.45M |
| September 30, 2023 | 41.46M |
| June 30, 2023 | 52.45M |
| March 31, 2023 | 60.28M |
| December 31, 2022 | 70.07M |
| September 30, 2022 | 76.64M |
| June 30, 2022 | 80.92M |
| Date | Value |
|---|---|
| March 31, 2022 | 94.04M |
| December 31, 2021 | 104.93M |
| September 30, 2021 | 121.06M |
| June 30, 2021 | 127.54M |
| March 31, 2021 | 139.17M |
| December 31, 2020 | 147.35M |
| September 30, 2020 | 154.99M |
| June 30, 2020 | 79.20M |
| March 31, 2020 | 83.07M |
| December 31, 2019 | 93.09M |
| September 30, 2019 | 93.58M |
| June 30, 2019 | 101.80M |
| March 31, 2019 | 107.14M |
| December 31, 2018 | 111.04M |
| September 30, 2018 | 117.50M |
| June 30, 2018 | 119.98M |
| March 31, 2018 | 126.21M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Biodexa Pharmaceuticals Plc | -- |
| Mereo BioPharma Group Plc | 34.71M |
| BioNTech SE | 23.26B |
| Silence Therapeutics Plc | 106.41M |
| Compass Pathways Plc | 504.56M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 7.330M |
| Shareholders Equity (Quarterly) | 26.89M |
| Debt to Equity Ratio | 0.0332 |
| Current Ratio | 4.729 |
| Net Debt Paydown Yield | -2.04% |